Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
CNBC
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
تحميل تطبيق نبأ للآندرويد مجانا
اقرأ على الموقع الرسمي
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
تحميل تطبيق نبأ للآندرويد مجانا